CJC-1295(no DAC) 5mg + Ipamorelin 5mg

Overview

This combination pairs CJC‑1295, a GHRH analog, with Ipamorelin, a selective ghrelin‑receptor agonist. It is referenced in scientific literature for studies involving endocrine signaling and peptide‑receptor interactions.

Research Focus

Researchers often explore this combination in relation to:

• GHRH receptor binding
• Ghrelin‑pathway signaling
• Peptide stability and synergistic receptor activity

Form: Lyophilized powder

Notice: For research use only. Not for human consumption.